Search Results for: mirgaine day of action/about:blank – Page 4

EMHA Call to Action.
March 23, 2021
Novartis announces AMG 334 significantly reduces patients’ monthly migraine days in phase II study of chronic migraine prevention
August 10, 2017 Industry News
Novartis’ Migraine prevention therapy is closer to being approved
June 4, 2018 Industry News
One Tough Challenge: Motherhood with Migraines
May 10, 2017 News Patients
EMHA for Media
January 21, 2021
Talking Head Pain Podcast
December 21, 2023 MigraineFriendlyWorkplace
New Migraine drug hailed as “Incredibly important” breakthrough
December 2, 2017 Industry Medical Community
Positive Phase III data for migraine drug Fremanezumab
July 1, 2017 Industry Medical Community
Xpatient-Congress-Barcelona-EMHA
XPatient Barcelona Congress 2021
October 25, 2021 Industry Medical Community
Migraine Friendly Workplace Stamp at work: The stamp that changes it all
September 15, 2021 Industry Medical Community
emha-20years
MENU
LATEST NEWS
ALL NEWS
SOCIAL
Facebook Instagram Twitter Youtube
Join our newsletter
Facebook Instagram Twitter Youtube

Join our newsletter.

Don't miss out on any updates! Join our community and discover 

the latest research, treatments, and events on migraine.
Subscribe now!

"*" indicates required fields

Email Adress*
Name*
Consent*
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.